Diabetes · East Greenwich, RI
Diabetes studies in East Greenwich, RI
4 recruiting studies have a site in East Greenwich.
4 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- East Greenwich, RI + 57 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Amgen
- Location
- East Greenwich, RI + 30 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- East Greenwich, RI + 69 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Housey Healthcare ULC
- Location
- East Greenwich, RI + 24 other US sites
- Eligibility basics
- Ages 18+
Who these studies look for
Studies commonly set an HbA1c range, a diagnosis duration and a list of allowed or excluded medications. Some also recruit people without diabetes as a comparison group.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.